Literature DB >> 34893010

Prevalence and genotype distribution of human papillomavirus infection among women aged 30-65 years in Xi'an, China: a population-based study of 14,655 women.

Xiaoxiao Han1, Guozhong Song1, Yufang Li2, Zhaoqiang Dong1, Xianchun Yan3, Suqing Wang4, Huizhen Tian1, Xiaohong Wu5, Chen Li5, Yi Huo6,7.   

Abstract

Cervical cancer is the fourth most common cancer among women worldwide in terms of both incidence and mortality. Persistent infection with high-risk human papillomavirus (HPV) has been identified as a cause of cervical intraepithelial neoplasia and invasive cervical cancer. The distribution of human papillomavirus genotypes varies regionally. To acquire baseline data on the population-based prevalence and genotype distribution of HPV infection, we investigated the molecular epidemiology of HPV infection among women in Xi'an, China. The study was conducted from September 2018 to December 2020. A total of 14,655 women aged 30-65 years were screened. The overall prevalence of HPV infection was 13.5% (95% confidence interval [CI]: 13.0-14.1%), with 10.4% of participants being positive for a single HPV type and 3.1% being positive for multiple HPV types. The prevalence of high-risk HPV (HR-HPV), low-risk HPV (LR-HPV) and mixed HPV infection was 10.1% (95% CI: 9.6-10.5%), 2.2% (95% CI: 2.0-2.4%), and 1.3% (95% CI: 1.1-1.5%), respectively. The five most frequently detected HR-HPV types were types 52 (2.6%), 16 (1.9%), 53 (1.8%), 58 (1.4%), and 51 (0.9%). The most frequently detected LR-HPV type was HPV-42 (1.1%). The prevalence and HPV genotype distribution varied by region and age. Age-specific HPV prevalence peaked in the over 60 years age group (18.8%), and Beilin District had the highest HPV prevalence (18.1%). The results of this first population-based study provide a reference for HPV-based cervical cancer screening and HPV vaccination programs in Xi'an.

Entities:  

Keywords:  China; Human papillomavirus infection; cervical cancer screening; general population; genotype distribution; prevalence survey

Mesh:

Year:  2021        PMID: 34893010      PMCID: PMC8903934          DOI: 10.1080/21645515.2021.2007709

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  41 in total

1.  Cervical cancer prevention in China: a key to cancer control.

Authors:  Fanghui Zhao; Youlin Qiao
Journal:  Lancet       Date:  2019-03-09       Impact factor: 79.321

Review 2.  Human papillomavirus molecular biology.

Authors:  Mallory E Harden; Karl Munger
Journal:  Mutat Res Rev Mutat Res       Date:  2016-07-05       Impact factor: 5.657

3.  Risk factors of invasive cervical cancer in Mali.

Authors:  Siné Bayo; F Xavier Bosch; Silvia de Sanjosé; Nubia Muñoz; Alba Lucia Combita; Pierre Coursaget; Mireia Diaz; Amardou Dolo; Adriaan J C van den Brule; Chris J M Meijer
Journal:  Int J Epidemiol       Date:  2002-02       Impact factor: 7.196

4.  Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.

Authors:  Silvia de Sanjose; Wim Gv Quint; Laia Alemany; Daan T Geraets; Jo Ellen Klaustermeier; Belen Lloveras; Sara Tous; Ana Felix; Luis Eduardo Bravo; Hai-Rim Shin; Carlos S Vallejos; Patricia Alonso de Ruiz; Marcus Aurelho Lima; Nuria Guimera; Omar Clavero; Maria Alejo; Antonio Llombart-Bosch; Chou Cheng-Yang; Silvio Alejandro Tatti; Elena Kasamatsu; Ermina Iljazovic; Michael Odida; Rodrigo Prado; Muhieddine Seoud; Magdalena Grce; Alp Usubutun; Asha Jain; Gustavo Adolfo Hernandez Suarez; Luis Estuardo Lombardi; Aekunbiola Banjo; Clara Menéndez; Efrén Javier Domingo; Julio Velasco; Ashrafun Nessa; Saibua C Bunnag Chichareon; You Lin Qiao; Enrique Lerma; Suzanne M Garland; Toshiyuki Sasagawa; Annabelle Ferrera; Doudja Hammouda; Luciano Mariani; Adela Pelayo; Ivo Steiner; Esther Oliva; Chris Jlm Meijer; Waleed Fahad Al-Jassar; Eugenia Cruz; Thomas C Wright; Ana Puras; Cecilia Ladines Llave; Maria Tzardi; Theodoros Agorastos; Victoria Garcia-Barriola; Christine Clavel; Jaume Ordi; Miguel Andújar; Xavier Castellsagué; Gloria I Sánchez; Andrzej Marcin Nowakowski; Jacob Bornstein; Nubia Muñoz; F Xavier Bosch
Journal:  Lancet Oncol       Date:  2010-10-15       Impact factor: 41.316

5.  Prevalence and genotype distribution of human papillomavirus among women from Henan, China.

Authors:  Xiao-Chuan Wang; Liang-Qi Sun; Li Ma; Hua-Xin Li; Xiu-Li Wang; Xin Wang; Tian Yun; Nian-Long Meng; Da-Le Lv
Journal:  Asian Pac J Cancer Prev       Date:  2014

6.  Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study.

Authors:  Sun Kuie Tay; Lynette Lin Ean Oon
Journal:  Int J STD AIDS       Date:  2014-03-19       Impact factor: 1.359

7.  PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort.

Authors:  Yafang Kang; Pengming Sun; Xiaodan Mao; Binhua Dong; Guanyu Ruan; Lihua Chen
Journal:  J Gynecol Oncol       Date:  2019-05       Impact factor: 4.401

8.  HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.

Authors:  Lingbo Jiang; Xinxin Tian; Dezhi Peng; Liran Zhang; Fengxiang Xie; Chunrui Bi; Rui Wang; Jiajia Wang; Debo Qi
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

9.  Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.

Authors:  Shannon Stokley; Jenny Jeyarajah; David Yankey; Maria Cano; Julianne Gee; Jill Roark; Robinette C Curtis; Lauri Markowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-07-25       Impact factor: 17.586

10.  HPV genotypic spectrum in Jilin province, China, where non-vaccine-covered HPV53 and 51 are prevalent, exhibits a bimodal age-specific pattern.

Authors:  Sijia Hao; Chunyan Wang; Siwen Liu; Jiaxue He; Yanfang Jiang
Journal:  PLoS One       Date:  2020-03-24       Impact factor: 3.240

View more
  2 in total

1.  Trends of cancer mortality in Xi'an City, China: 2005-2020.

Authors:  Ning Chen; Xiao-Yu Zhang; Lin-Lin Ma; Guo-Dong Zhao; Yu-Xiang Yan
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-14       Impact factor: 4.322

2.  Genetic variability of E6 and E7 genes of human papillomavirus type 58 in Jingzhou, Hubei Province of central China.

Authors:  Zhiping Yang; Chunlin Zhang; Ping Luo; Mengxia Ye; Quan Gong; Bing Mei
Journal:  Virol J       Date:  2022-04-22       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.